| Alimera Sciences, Inc. ALIM | $65.66M | 32.14 | 16.84M | 0% | +$0 | 17.36 | |
| Liquidia Corporation LQDA | $152.82M | 13.57 | 10.36M | 0% | +$0 | 40.4 | |
| Verona Pharma plc VRNA | $20.86M | 12.79 | 1.3M | +608.19% | +$17.91M | 5.51 | |
| Anika Therapeutics, Inc. ANIK | $36.47M | 9.68 | 1.44M | +32.8% | +$9.01M | 9.64 | |
| Enanta Pharmaceuticals, Inc. ENTA | $14.98M | 4.05 | 858,070 | New | +$14.98M | 3.96 | |
| Evolus, Inc. EOLS | $26.44M | 3.02 | 1.89M | +43.33% | +$7.99M | 6.99 | |
| Outlook Therapeutics, Inc. OTLK | $5.97M | 2.14 | 500,000 | New | +$5.97M | 1.58 | |
| Y-mAbs Therapeutics, Inc. YMAB | $9.55M | 1.34 | 587,276 | -43.98% | -$7.5M | 2.52 | |
I-Mab IMAB | $1.41M | 0.94 | 756,538 | New | +$1.41M | 0.37 | |
Agios Pharmaceuticals, Inc. AGIO | $14.17M | 0.85 | 484,711 | +9.71% | +$1.25M | 3.75 | |
| Exelixis, Inc. EXEL | $26.12M | 0.38 | 1.1M | +20.86% | +$4.51M | 6.9 | |
| BioCryst Pharmaceuticals, Inc. BCRX | $3.85M | 0.37 | 758,502 | New | +$3.85M | 1.02 |